Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 55 | 0 | 1986 | 2020 | ||||||||
|
melanocortin 1 receptor | 0.524 | 0.808 | 8.1E-11 |
|
disease | 0.500 | None | 0.959 | 17 | 0 | 1996 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.969 | 16 | 0 | 1987 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.943 | 15 | 0 | 1991 | 2020 | ||||||||
|
melanocyte inducing transcription factor | 0.499 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.974 | 13 | 0 | 2002 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.986 | 11 | 0 | 1996 | 2020 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.500 | None | 0.984 | 10 | 0 | 1988 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 0.981 | 10 | 0 | 1994 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 0.943 | 8 | 0 | 1996 | 2020 | ||||||||
|
MIA SH3 domain containing | 0.537 | 0.769 | 1.7E-05 |
|
disease | 0.100 | None | 0.975 | 8 | 0 | 1991 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.500 | None | 0.967 | 8 | 0 | 1992 | 2020 | ||||||||
|
apoptotic peptidase activating factor 1 | 0.525 | 0.769 | 9.6E-06 |
|
disease | 0.100 | None | 0.933 | 8 | 0 | 2001 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 7 | 0 | 2004 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.200 | None | 1.000 | 7 | 0 | 2004 | 2020 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 0.976 | 7 | 0 | 1989 | 2019 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.090 | None | 1.000 | 7 | 0 | 1996 | 2018 | ||||||||
|
integrin subunit alpha V | 0.526 | 0.769 | 2.3E-04 |
|
disease | 0.100 | None | 1.000 | 7 | 0 | 1989 | 2016 | ||||||||
|
melan-A | 0.579 | 0.692 | 1.3E-09 |
|
disease | 0.400 | None | 0.982 | 7 | 0 | 1994 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.976 | 6 | 0 | 1991 | 2020 | ||||||||
|
integrin subunit beta 1 | 0.496 | 0.808 | 0.98 |
|
disease | 0.080 | None | 1.000 | 6 | 0 | 2000 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 6 | 0 | 2001 | 2020 | ||||||||
|
cadherin 2 | 0.535 | 0.731 | 0.99 |
|
disease | 0.080 | None | 1.000 | 6 | 0 | 2000 | 2017 | ||||||||
|
melanotransferrin | 0.663 | 0.500 | 1.2E-16 |
|
disease | 0.400 | None | 0.929 | 5 | 0 | 1986 | 2009 | ||||||||
|
BCL2 like 11 | 0.510 | 0.731 | 0.89 |
|
disease | 0.060 | None | 1.000 | 5 | 0 | 2006 | 2017 | ||||||||
|
melanoma cell adhesion molecule | 0.514 | 0.731 | 1.6E-04 |
|
disease | 0.100 | None | 0.959 | 5 | 0 | 1989 | 2019 |